Bristol-Myers Squibb
BMY | NYSE
$62.48
+$1.09 (+1.78%)
At close: Oct 30, 2026, 4:00 PM ET
$62.39
-$0.09 (-0.14%)
Pre-market:
Nov 2, 2026, 4:03 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 15.59 | -12.83 | 13.22 | 24.23 | 19.79 | -15.59 |
PEG Ratio | -0.09 | 0.06 | 0.43 | -4.24 | -0.11 | 0.05 |
PS Ratio | 2.28 | 2.37 | 2.36 | 3.32 | 2.99 | 3.29 |
PB Ratio | 5.96 | 7.02 | 3.61 | 4.93 | 3.85 | 3.70 |
P/FCF Ratio | 8.57 | 8.22 | 8.39 | 12.83 | 9.09 | 10.53 |
P/OCF Ratio | 7.78 | 7.55 | 7.66 | 11.73 | 8.54 | 9.97 |
OCF/S Ratio | 29.37 | 31.45 | 30.80 | 28.31 | 34.94 | 33.05 |
Debt / Equity Ratio | 2.55 | 3.13 | 1.41 | 1.31 | 1.27 | 1.37 |
Quick Ratio | 1.14 | 1.15 | 1.31 | 1.14 | 1.43 | 1.47 |
Current Ratio | 1.26 | 1.25 | 1.43 | 1.25 | 1.52 | 1.58 |
Asset Turnover | 0.54 | 0.52 | 0.47 | 0.48 | 0.42 | 0.36 |
Interest Coverage | 7.26 | 3.02 | 7.03 | 7.39 | 6.40 | 1.53 |
Return on Equity | 38.19% | -54.78% | 27.27% | 20.37% | 19.46% | -23.84% |
Return on Assets | 7.83% | -9.66% | 8.43% | 6.53% | 6.40% | -7.61% |
Return on Invested Capital | 15.03% | 8.29% | 10.25% | 9.44% | 7.99% | 2.14% |
Dividend Yield | 4.58% | 4.24% | 4.47% | 3.02% | 3.17% | 2.91% |
Payout Ratio | 71.52% | -54.35% | 59.12% | 73.24% | 62.85% | -45.20% |
FCF Payout Ratio | 41.04% | 36.20% | 39.10% | 40.33% | 30% | 32.55% |
Gross Profit Margin | 71.08% | 71.08% | 76.24% | 78.04% | 78.57% | 72.31% |
Net Profit Margin | 14.64% | -18.53% | 17.83% | 13.71% | 15.08% | -21.20% |
Pretax Profit Margin | 19.35% | -17.35% | 18.75% | 16.71% | 17.46% | -16.16% |
Operating Profit Margin | 28.48% | 12.19% | 18.21% | 19.72% | 18.40% | 5.12% |
FCF Margin | 26.65% | 28.87% | 28.11% | 25.88% | 32.84% | 31.28% |
EBITDA Margin | 31.60% | 6.56% | 43.03% | 41.64% | 43.37% | 11.59% |
Add to Watchlist
Select watchlists to add or remove BMY